Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome

Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome

US Patent 8222240 · Granted Jul 17, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic ac2021
Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjug2020
Conjugates comprising an GLP-1/glucagon dual agonist, a linker and hyaluronic ac2020
Exendin-4 derivatives as dual GLP1/glucagon agonists2020
Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists2020
Compounds as peptidic GLP1/glucagon/GIP receptor agonists2019
Functionalized Exendin-4 derivatives2019
Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonist2018
Exendin-4 derivatives as selective glucagon receptor agonists2018
Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obes2018
Substituted indanone compounds as GPR119 modulators for the treatment of diabete2018
Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonists2017